MedPath

Etodolac

Generic Name
Etodolac
Brand Names
Lodine
Drug Type
Small Molecule
Chemical Formula
C17H21NO3
CAS Number
41340-25-4
Unique Ingredient Identifier
2M36281008
Background

Etodolac is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic properties. Its therapeutic effects are due to its ability to inhibit prostaglandin synthesis. It is indicated for relief of signs and symptoms of rheumatoid arthritis and osteoarthritis.

Indication

For acute and long-term management of signs and symptoms of osteoarthritis and rheumatoid arthritis, as well as for the management of pain.

Associated Conditions
Acute Pain, Chronic Back Pain, Extra-Articular Rheumatism, Juvenile Idiopathic Arthritis (JIA), Muscle Spasms, Nonspecific Pain Post Traumatic Injury, Osteoarthritis (OA), Postoperative pain, Rheumatoid Arthritis, Spinal Disorders

MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains

Phase 3
Completed
Conditions
Ankle Sprains
Interventions
Drug: MRX-7EAT
Drug: Placebo
First Posted Date
2010-09-10
Last Posted Date
2018-01-17
Lead Sponsor
MEDRx USA, Inc.
Target Recruit Count
600
Registration Number
NCT01198834

A Study to Verify the Efficacy of YM177 (Celecoxib) in Postoperative Pain Patients

Phase 3
Completed
Conditions
Post Operative Pain
Interventions
First Posted Date
2010-05-06
Last Posted Date
2014-10-15
Lead Sponsor
Astellas Pharma Inc
Target Recruit Count
616
Registration Number
NCT01118572

Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer Surgery

Not Applicable
Conditions
Primary Operable Breast Cancer
Interventions
First Posted Date
2007-07-18
Last Posted Date
2014-07-01
Lead Sponsor
Kaplan Medical Center
Target Recruit Count
32
Registration Number
NCT00502684
Locations
🇮🇱

Rabin Medical Center, Petah Tikva, Israel

🇮🇱

Kaplan Medical Center, Rehovot, Israel

🇮🇱

Sheba Medical Center, Ramat Gan, Israel

© Copyright 2025. All Rights Reserved by MedPath